SEC Form D private-offering filing

IN8BIO, INC.

A new SEC Form D private-offering notice from New York, NY, a $40,239,043 filer-stated offering target in Biotech. The source filing is one click away.

IN8BIO, INC. site↗ Verified via SEC Form D

Clinical-stage biopharmaceutical company developing gamma-delta T cell therapies and T cell engagers for cancer, with Phase 1/2 programs in glioblastoma and leukemia.

Filed 2025-12-30Filed to raise $40,239,043First money in 2025-12-22Raised so far $20,119,049HQ (as filed) New York, NYSector Biotech ✓Stage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Website verified in8bio.com↗Named in the filing 10 executives & directors
Open this row on the live feed →More new filings in New York →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.